Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience

Authors: Carolina Oi Lam Ung, Joanna Harnett, Hao Hu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Although pharmacists are entrusted to play a role in ensuring the safe and appropriate use of all medicines, in general, the inclusion of complementary medicines (CMs) into their professional practice has not been observed. The purpose of this study was to explore the perceptions and opinions of pharmacists and 8 key stakeholder leaders regarding the barriers that hinder pharmacists from providing care related to the use of CMs by patients/consumers and to identify solutions that would support pharmacists’ in extending their role in this area.

Methods

Semi-structured key informant interviews were conducted with 2 practicing pharmacists, 1 pharmacy owner, 1 key representative of a pharmacist professional organization, 1 key representative of a consumer advocacy group, 1 key representative of a medical professional organization, 1 key representative from a complementary medicine practitioner professional organization, 1 leader within a pharmacy school, 2 senior staff from a regulatory authority, and 1 key representative of the complementary medicine industry in Australia.

Results

A total of 9 barriers were identified in this study. Barriers including a lack of CMs knowledge, doubts about the evidence-base, a lack of research skills and access to reliable and reputable information dominated the discussions. A total of 7 solutions were proposed. Of those, the integration of CMs curricula into under-graduate and professional pharmacy education, and defining a clearer role for pharmacists’ standard of practice were considered the most important. Apposing opinions about the role of naturopaths in pharmacies were identified..

Conclusion

It is anticipated that pharmacists will be required to formalise a role in ensuring the safe and appropriate use of complementary medicines to fulfil their professional and ethical responsibilities. However, pharmacists in general are not ready to take up this extended role. Individual key stakeholder groups have considered the existing barriers and have proposed solutions that are isolated measures. To facilitate further developments related to CMs and the professional practice of pharmacy, collaborative efforts between key stakeholders are needed to strategically plan and execute an extended role in a unified manner.
Literature
1.
2.
3.
Robinson MM, Zhang X. The world medicines situation 2011 (traditional medicines: global situation, issues and challenges). Geneva: World Health Organization; 2011.
4.
5.
6.
7.
Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007;13(6):643–50.CrossRefPubMed
8.
Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;18:1–14.
9.
10.
11.
12.
13.
14.
Kanjanarach T, Krass I, Cumming R. Exploratory study of factors influencing practice of pharmacists in Australia and Thailand with respect to dietary supplements and complementary medicines. Int J Pharm Pract. 2006;14:123–8.CrossRef
15.
Koh HL, Teo HH, Ng HL. Pharmacists’ patterns of use, knowledge, and attitudes toward complementary and alternative medicine. J Altern Complement Med. 2003;9:51–63.CrossRefPubMed
16.
McHughes M, Timmermann BN. A review of the use of CAM therapy and the sources of accurate and reliable information. J Manag Care Pharm. 2005;11:695–703.PubMed
17.
Hirschkorn KA. Exclusive versus everyday forms of professional knowledge: legitimacy claims in conventional and alternative medicine. Sociol Health Illn. 2006;28(5):533–57.CrossRefPubMed
18.
Hasan SS, Ahmed SI, Bukhari NI, Loon WC. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15(3):152–7.CrossRefPubMed
19.
Xu J, Yang Y. Traditional Chinese medicine in the Chinese health care system. Health Policy. 2009;90:133–9.CrossRefPubMed
20.
Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone survey. JAMA. 2002;287(3):337–44.CrossRefPubMed
21.
Thomson P, et al. Why people seek complementary and alternative medicine before conventional medical treatment: a population based study. Complement Ther Clin Pract. 2014;20:339–46.CrossRefPubMed
22.
Williamson M, Tudball J, Toms M, Garden F, Grunseit A. Information use and needs of complementary medicines users. Sydney: National Prescribing Service; 2008.
23.
24.
Iyer P, McFarland R, La Caze A. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff. Int J Pharm Pract. 2016;16
25.
26.
Boon H. CAM and Pharmacists: challenge or opportunity? Focus Alternative Complementary Therapies. 2005;10(2):1–3.
27.
28.
29.
Miller LG, Hume A, Harris IM, et al. White paper on herbal products. American College of Clinical Pharmacy Pharmacotherapy. 2000;20(7):877–91.PubMed
30.
Walji R, Boon H, Barnes J, Welsh S, Austin Z, Baker GR. Reporting natural health product related adverse drug reactions: is it the pharmacist’s responsibility? Int J Pharm Pract. 2011;19(6):383–91.CrossRefPubMed
31.
Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3):513–8.CrossRefPubMed
32.
33.
34.
Metcalfe A, Williams J, McChesney J, Patten SB, Jette N. Use of complementary and alternative medicine by those with a chronic disease and the general population the results of a national population based survey. BMC Complement Altern Med. 2010;10:58.CrossRefPubMedPubMedCentral
35.
Pollow RL, Stoller EP, Forster LE, Duniho TS. Drug combinations and potential for risk of adverse drug reaction among community-dwelling elderly. Nurs Res. 1994;43(1):44–9.CrossRefPubMed
36.
Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55(6):515–25.CrossRefPubMedPubMedCentral
37.
Hu Z, Yang X, Ho PC, et al. Herb–drug interactions: a literature review. Drugs. 2005;65(9):1239–82.CrossRefPubMed
38.
Kwan D, Boon HS, Hirschkorn K, Welsh S, Jurgens T, Eccott L, Heschuk S, Griener GG, Cohen-Kohler JC. Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups. BMC Complementary Alternative Medicine. 2008;8:40.CrossRefPubMedPubMedCentral
39.
Ung COL, Harnett J, Hu H. Community pharmacist’s responsibilities with regards to traditional medicine/complementary medicine products: a systematic literature review. Res Social Adm Pharm. 2017;13(4):686–716.
40.
Tiralongo E, Braun L, Wilkinson J, Spizer O, Bailey M, Poole S, Dooley M. Exploring the integration of complementary medicines into Australian pharmacy practice with a focus on different practice settings and background knowledge. J Complement Integr Med. 2010;7:1–23.CrossRef
41.
42.
43.
D’Onise K, Haren MT, Misan GM, McDermott RA. Who uses complementary and alternative therapies in regional South Australia? Evidence from the Whyalla intergenerational study of health. Aust Health Rev. 2013;37(1):104–11.CrossRefPubMed
44.
McLaughlin D1, Lui CW, Adams J. Complementary and alternative medicine use among older Australian women--a qualitative analysis. BMC Complement Altern Med. 2012;12:34.CrossRefPubMedPubMedCentral
45.
Sibbritt D, Adams J, Lui CW, Broom A, Wardle J. Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older. PLoS One. 2012;7(7):e41540.CrossRefPubMedPubMedCentral
46.
Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer. 2011;11:196.CrossRefPubMedPubMedCentral
47.
Grant SJ, Bin YS, Kiat H, Chang DH. The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health. 2012;12:299.CrossRefPubMedPubMedCentral
48.
Braun LA, Cohen M. Use of complementary medicines by cardiac surgery patients; undisclosed and undetected. Heart Lung Circ. 2011;20(5):305–11.CrossRefPubMed
49.
Spinks J, Hollingsworth B, Manderson L, Lin V, Canaway R. Costs and drivers of complementary and alternative medicine (CAM) use in people with type 2 diabetes or cardiovascular disease. Eur J Int Med. 2013;5(1):44–53.CrossRef
50.
Murthy V, Sibbritt D, Adams J, Broom A, Kirby E, Refshauge KM. Self-prescribed complementary and alternative medicine use for back pain amongst a range of care options: results from a nationally representative sample of 1310 women aged 60–65 years. Complement Ther Med. 2014;22(1):133–40.CrossRefPubMed
51.
Kirby ER, Broom AF, Sibbritt DW, Adams J, Refshauge KM. A national cross-sectional survey of back pain care amongst Australian women aged 60–65. Eur J Int Med. 2013;5(1):36–43.CrossRef
52.
Adams J, Sibbritt D, Lui CW. The use of complementary and alternative medicine during pregnancy: a longitudinal study of Australian women. Birth. 2011;38(3):200–6.CrossRefPubMed
53.
Sim TF, Sherriff J, Hattingh HL, Parsons R, Tee LB. The use of herbal medicines during breastfeeding: a population-based survey in Western Australia. BMC Complement Altern Med. 2013;13:317.CrossRefPubMedPubMedCentral
54.
Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196(1):50–3.CrossRefPubMed
55.
Braun LA, Tiralongo E, Wilkinson JM, Poole S, Spitzer O, Bailey M, Dooley M. Adverse reactions to complementary medicines: the Australian pharmacy experience. Int J Pharm Pract. 2010;18(4):242–4.CrossRefPubMed
56.
Moses GM, McGuire TM. Drug interactions with complementary medicines. Aust Prescr. 2010;33:177–80.CrossRef
57.
58.
59.
60.
61.
Joyce AW, Sunderland VB, Burrows S, McManus A, Howat P, Maycick B. Community pharmacy’s role in promoting healthy behaviours. J Pharm Pract Res. 2007;37:42–4.CrossRef
62.
Kanjanarach T, Krass I, Cumming R. Australian community pharmacists’ practice in complementary medicines: a structural equation modeling approach. Patient Educ Couns. 2011;83:352–9.CrossRefPubMed
63.
Braun LA, Tiralongo E, Wilkinson JM, Spitzer O, Bailey M, Poole S, Dooley M. Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med. 2010;10:38.CrossRefPubMedPubMedCentral
64.
Guirguis K. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions. Consult Pharm. 2010;25(7):433–9.CrossRefPubMed
65.
Bushett NJ, Dickson-Swift VA, Willis JA, Wood P. Rural Australian community pharmacists’ views on complementary and alternative medicine: a pilot study. BMC Complement Altern Med. 2011;11:103.CrossRefPubMedPubMedCentral
66.
Kwan D, Hirschkorn K, Boon H. U.S. and Canadian pharmacists’ attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review. BMC Complement Altern Med. 2006;6:31.CrossRefPubMedPubMedCentral
67.
Asahina Y, Hori S, Sawada Y. Community pharmacists’ attitudes relating to patients’ use of health products in Japan. Int J Clin Pharm. 2012;34(4):529–37.CrossRefPubMed
68.
Tran S, Calabretto JP, Sorich M. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence. Int J Pharm Pract. 2013;21(6):378–85.CrossRefPubMed
69.
Welna EM, Hadsall RS, Schommer JC. Pharmacists’ personal use, professional practice behaviors, and perceptions regarding herbal and other natural products. J Am Pharm Assoc. 2003;43(5):602–11.CrossRef
70.
Braun L, Cohen M. Australian hospital pharmacists’ attitudes, perceptions, knowledge and practices of CAMs. J Pharm Pract Res. 2007;37(3):220–3.CrossRef
71.
Brown JA, Roufogalis BD, Williamson M. Complementary medicines: hospital pharmacists’ attitude, knowledge and information seeking behaviour. J Pharm Pract Res. 2009;39:281–5.CrossRef
72.
73.
Freymann H, Rennie T, Bates I, Nebel S, Heinrich M. Knowledge and use of complementary and alternative medicine among British undergraduate pharmacy students. Pharm World Sci. 2006;28:13–8.CrossRefPubMed
74.
Kreitzer MJ, Mitten D, Harris I, Shandeling J. Attitudes toward CAM among medical, nursing, and pharmacy faculty students: a comparative analysis. Altern Ther Health Med. 2002;8(44–7):50–3.
75.
Tiralongo E, Wallis M. Attitudes and perceptions of Australian pharmacy students towards complementary and alternative medicine - a pilot study. BMC Complement Altern Med. 2008;8:2.CrossRefPubMedPubMedCentral
76.
Sewitch MJ, Cepoiu M, Rigillo N, Sproule D. A literature review of health care professional attitudes toward complementary and alternative medicine. Complement Health Pract Rev. 2008;13:139–54.CrossRef
77.
Naidu S, Wilkinson J, Simpson M. Attitudes of Australian pharmacists toward complementary and alternative medicines. Ann Pharmacother. 2005;39:1456–61.CrossRefPubMed
78.
Semple SJ, Hotham E, Rao D, Martin K, Smith CA, Bloustien GF. Community pharmacists in Australia: barriers to information provision on complementary and alternative medicines. Pharm World Sci. 2006;28:366–73.CrossRefPubMed
79.
80.
Brooks PM. It’s time to plan our future health system. Med J Aust. 2005;183:545.PubMed
81.
Brooks PM. Undergraduate teaching of complementary medicine. Med J Aust. 2004;181:275.PubMed
82.
Owen D, Lewith GT. Teaching integrated care: CAM familiarisation courses. Med J Aust. 2004;181:276–8.PubMed
83.
Mills E, Hollyer T, Saranchuk R, Wilson K. Teaching evidence-based complementary and alternative medicine (EBCAM); changing behaviours in the face of reticence: a cross-over trial. BMC Med Educ. 2002;2:2.CrossRefPubMedPubMedCentral
84.
Taing MW, Tan ETX, Williams GM, Clavarino AM, McGuire TM. Herbal and nutrient complementary medicines for weight loss: community pharmacists’ practices, attitudes, recommendations, information and education needs. Int J Pharm Pract. 2016;24:160–9.CrossRefPubMed
85.
Culverhouse SE, Wohlmuth H. Factors affecting pharmacists’ recommendation of complementary medicines – a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12:183.CrossRefPubMedPubMedCentral
86.
Easton K and National Prescribing Service (Australia). Complementary medicines : attitudes and information needs of consumers and healthcare professionals. National Prescribing Service Limited, Surry Hills, N.S.W; 2007.
87.
Banks J, Shaw A, Weiss MC. The community pharmacy and discursive complexity: a qualitative study of interaction between counter assistants and customers. Health Soc Care Community. 2007;15:313–21.CrossRefPubMed
88.
Stevenson FA, Leontowitsch M, Duggan C. Over the-counter medicines: professional expertise and consumer discourses. Sociol Health Illn. 2008;30:913–28.CrossRefPubMed
89.
Iyer P, McFarland R, La Caze A. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff. Int J Pharm Pract. 2017;25(4):292–300.
90.
Bensoussan A, Lewith GT. Complementary medicine research in Australia: a strategy for the future. Med J Aust. 2004;181(6):331–3.PubMed
91.
92.
McGuire TM, Walters JA, Dean AJ, Van Driel M, Del Mar C, Kotsirilos V, Moses GM, Chong S, Deed G, Eldred B, Hardy J, Heussler H, Hollingworth S, Marron L, Mendel J, Pache D, Steadman K, Trenerry H, Brown J, Williamson M. Review of the quality of complementary medicines information resources: Summary report. Australia: National prescribing service limited; 2009. p. 1-54.
93.
Brown JMT, et al. Complementary medicines information use and needs of health professionals: general practitioners and pharmacists. Sydney: National Prescribing Service; 2008.
94.
van Eikenhorst L, Salema NE, Anderson C. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy. Res Social Adm Pharm. 2017;13(1):17–38.
95.
Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P. Nonprescription drug related problems and pharmacy interventions. Ann Pharmacother. 2001;35:1343–9.CrossRefPubMed
Metadata
Title
Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience
Authors
Carolina Oi Lam Ung
Joanna Harnett
Hao Hu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1899-5

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue

Research article

Alpinia oxyphylla Miq. fruit extract activates IGFR-PI3K/Akt signaling to induce Schwann cell proliferation and sciatic nerve regeneration

Research article

Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey

Research article

Hepatoprotective effect of the solvent extracts of Viola canescens Wall. ex. Roxb. against CCl4 induced toxicity through antioxidant and membrane stabilizing activity

Research article

Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines

Research article

Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury

Research article

Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections